← Open Payments lookup

GHULAM MURTAZA BAJWA: Open Payments

NPI 1073713814 · PARAMUS, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$979 in 70 payments from 10 companies in 2025. Trend: 2023 $1,491 · 2024 $1,073 · 2025 $979

Food & beverage: $979
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)16$235
E.R. Squibb & Sons, L.L.C.15$169
Lundbeck LLC14$162
Otsuka America Pharmaceutical, Inc.5$100
ABBVIE INC.5$76
Teva Pharmaceuticals USA, Inc.4$70
Vanda Pharmaceuticals Inc.4$60
Janssen Pharmaceuticals, Inc3$46
Supernus Pharmaceuticals, Inc.3$44
Axsome Therapeutics, Inc.1$19

Products named: CAPLYTA, REXULTI, COBENFY, VRAYLAR, UZEDY, ABILIFY ASIMTUFII, HETLIOZ, INVEGA SUSTENNA.

Industry payments across NJ — which companies pay providers there.